{"id":6276,"date":"2015-03-24T11:28:49","date_gmt":"2015-03-24T15:28:49","guid":{"rendered":"http:\/\/www.achooallergy.com\/blog\/?p=6276"},"modified":"2025-12-18T01:49:06","modified_gmt":"2025-12-18T06:49:06","slug":"news-and-notes-in-allergies-asthma","status":"publish","type":"post","link":"https:\/\/www.achooallergy.com\/blog\/news-and-notes-in-allergies-asthma\/","title":{"rendered":"News and Notes in Allergies, Asthma, & MCS"},"content":{"rendered":"

Allergy asthma news is essential for staying informed about the latest research, treatment options, and lifestyle strategies for managing allergies, asthma, and multiple chemical sensitivities (MCS). For those living with these conditions, understanding emerging developments can make a meaningful difference in symptom management, overall health, and quality of life. Staying up to date also helps patients, caregivers, and healthcare professionals make informed decisions about care plans and environmental adjustments.<\/p>\n

Recent updates in the field have highlighted advances in diagnostic tools, treatment approaches, and environmental management techniques. Allergy and asthma research is continuously evolving, with studies identifying new triggers, better prevention strategies, and innovative therapies designed to reduce symptom severity. Multiple chemical sensitivity, often overlooked, is gaining recognition as researchers explore ways to mitigate exposure to everyday chemicals that exacerbate symptoms in sensitive individuals.<\/p>\n

Following allergy asthma news also helps readers understand practical, everyday applications of these findings. This can include advice on air quality improvement, allergen reduction strategies, and guidance for safely managing symptoms at home, at work, or in public spaces. Being informed allows individuals to take proactive steps to protect their respiratory health and overall well-being.<\/p>\n

By regularly monitoring updates and expert insights, those affected by allergies, asthma, or MCS can make more informed choices about treatment, lifestyle changes, and preventive measures. Allergy asthma news ensures readers are not only aware of the latest scientific developments but also empowered to apply these insights in practical, meaningful ways to support a healthier, more comfortable life.<\/p>\n

Last week, we took a little time off from posting. As you may have noticed, Miele is completely renaming their entire line of HEPA vacuum cleaners<\/a>, and it has created a lot of new work for us here at AchooAllergy<\/a>. But it’s Tuesday, and we’re back! I wanted to start with a roundup of some of the recent news and notes in allergies, asthma, and environmental control.<\/p>\n

Reaching back the furthest is the announcement earlier this month that there was a proposed class action lawsuit filed against Lumber Liquidators. While traditional home improvement is necessarily something you’ll see us writing about, this story was of particular note. \"NewsFor many with severe allergies or asthma, a recommendation your allergist or physician will often recommend is to replace your carpet with smooth flooring. This can be anything from linoleum or hardwoods to tile or laminate. None of these will trap and retain allergens and irritants as carpet does. This story broke on 60 Minutes<\/em>, and focused on laminate flooring and levels of formaldehyde in the product. As we’ve often mentioned, formaldehyde is a common but powerful volatile organic compound (VOC) linked to a wide variety of conditions. Formaldehyde found in glues, adhesives, new furniture, and carpet can often aggravate respiratory conditions like allergies or asthma and severely impact those with chemical sensitivities. More generally, formaldehyde is a known carcinogen, and the result of long-term exposure to any carcinogen is almost always the same – cancer.<\/p>\n

\"CourtAt this point, there is plenty to be said on both sides. Some within the flooring industry attack the test or testing methods, which are performed by the California Air Resources Board (CARB), the same folks who test home air purifiers to ensure they do not produce ozone. Others have lambasted the company, Lumber Liquidators, as well as the manufacturers in China. While blame and claims fly, and a court battle is likely to drag on for years, there are a couple of things to take from this story.<\/p>\n

First, while all laminates contain some level of these VOCs, most have minimal levels that are within limits set by the CARB. CARB has some of the most rigorous testing in the world, with regard to emissions, ozone, and other potential indoor pollutants, and while some \"VOCsmay take issue with how this particular test is performed, it’s worth noting that the same testing of products sold by other home improvement stores revealed no issues with elevated levels of formaldehyde. Think of this like paint. Most interior paints contain some level of VOCs, but there are some that have lower levels than others.<\/p>\n

Second, remember the source. While products of all types, made in a variety of countries, can and do have problems (think of the string of auto recalls in the last several years), in this instance it was only laminate made in China that so dismally failed CARB tests.<\/p>\n

I’m not saying every product that comes out of China is bad or dangerous, but by this point, we should have had enough reason to be somewhat leery (drywall in 2001, toxic pet treats in 2007, melamine in milk in 2008, heavy metals found in toys’ paint in 2011). Do a little extra research. The internet has a wealth of information, and in a short amount of time, you can often double-check a company’s claim about its product. I’d also advise you to consider the source of your information. “Jimbo’s Awesome Blog” might not necessarily be as credible as a piece found on a major news site or National Institute of Health page.<\/p>\n

The second story I wanted to mention was likely missed by many, but it involves the drug Breo\u00ae Ellipta\u00ae by GlaxoKlineSmith. Commonly used to treat those with COPD, there has been scrutiny on the drug over its potential use by adolescents and children or for any condition other than COPD (which is comprised of emphysema and chronic bronchitis). \"Breo\u00aeAn FDA advisory panel overwhelmingly voted against the use of Breo\u00ae Ellipta\u00ae in children 12-17. For now, the drug will remain a COPD drug and NOT an asthma medication.<\/p>\n

This isn’t the first time an issue like this has arisen. Breo\u00ae is a two part drug which contains a corticosteroid<\/a> as well as a long-acting beta-agonist (LABA). LABAs have and continue to be scrutinized for their links to increased risk of death in those who have asthma and use this class of medication. A quick glance at the official Breo\u00ae website<\/a> should give you a pretty clear indicator of this as the warning that this drug is NOT to be used for asthma appears repeatedly on their site.<\/p>\n

\"NewsLastly, today was not the day to be a Parisian resident with an even numbered license plate, particularly a joyride was on the daily to-do list. As has happened in Paris before, extremely high levels of air pollution have made the city the smoggiest on the planet, if only briefly dethroning Beijing and\/or New Delhi. While a view of the skyline may appear rather miserable today, it likely won’t last long.<\/p>\n

As a final note, April is almost here, and in addition to the dogwoods being in full bloom this weekend, our most dreaded spring allergens are beginning to emerge from their winter slumber. Nicer weather shepherding in weeks of sneezing, congestion, and sinus pressure. Thanks nature!<\/em><\/p>\n

To see the entire 60 Minutes piece about flooring<\/a>.<\/p>\n

Author: KevvyG<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Allergy asthma news is essential for staying informed about the latest research, treatment options, and lifestyle strategies for managing allergies, asthma, and multiple chemical sensitivities (MCS). For those living with these conditions, understanding emerging developments can make a meaningful difference… <\/p>\n